Cenerimod — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-31 in 3mo
ESTIMATED |
READOUT
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Su
Phase 3 · Lupus Erythematosus, Systemic |
Viatris Innovation GmbH | Cenerimod |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|